Filing Details
- Accession Number:
- 0001209191-21-045957
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-07 21:13:39
- Reporting Period:
- 2021-07-02
- Accepted Time:
- 2021-07-07 21:13:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566373 | F-Star Therapeutics Inc. | FSTX | Pharmaceutical Preparations (2834) | 522386345 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831519 | Louis Kayitalire | C/O F-Star Therapeutics, Inc. Eddeva B920, Babraham Research Campus Cambridge X0 CB22 3AT | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-07-02 | 1,054 | $8.43 | 54,383 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
- Includes 48,828 restricted stock units.
Billionaire Hedge Funds
